Lynsight Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $649K

  • Investors
  • 8

Lynsight General Information

Description

Developer of a predictive cancer diagnostic technology intended to reduce cancer mortality rates. The company's technology offers a functional test that can be used for the diagnosis of MMR deficiency and simplifies the diagnostics of Lynch syndrome by delivering predictive and accurate results with a cost-efficient method globally, enabling patients to save their lives through early detection of cancer.

Contact Information

Website
www.lynsightlabs.com
Formerly Known As
LS CancerDiag
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Arabiankatu 12
  • 00560 Helsinki
  • Finland
+358 040
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Vertical(s)
Digital Health, Life Sciences, Oncology
Corporate Office
  • Arabiankatu 12
  • 00560 Helsinki
  • Finland
+358 040

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lynsight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Equity Crowdfunding $649K Completed Generating Revenue
10. Equity Crowdfunding 01-May-2023 Completed Generating Revenue
9. Seed Round 30-Jun-2020 Completed Generating Revenue
8. Accelerator/Incubator 17-May-2020 Completed Generating Revenue
7. Accelerator/Incubator 24-Apr-2020 Completed Startup
6. Accelerator/Incubator 01-Jan-2020 Completed Startup
5. Accelerator/Incubator 01-Jan-2019 Completed Startup
4. Seed Round 11-Sep-2018 Completed Startup
3. Accelerator/Incubator 01-Jan-2016 $521K Completed Startup
2. Seed Round 28-Sep-2015 $521K $521K Completed Startup
To view Lynsight’s complete valuation and funding history, request access »

Lynsight Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 18,678 $9.81 $9.81 1x $9.81 1.43%
Ordinary 111,946 $3.01 $3.01 1x $3.01 8.55%
To view Lynsight’s complete cap table history, request access »

Lynsight Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • Pending

  • Expiring in next 12 mo

Lynsight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018224731-A1 A method for determining whether a subject is at risk to develop cancer and tools related thereto Inactive 05-Jun-2017
AU-2012280397-A1 Method to determine dna mismatch repair function Active 01-Jul-2011
AU-2012280397-B2 Method to determine dna mismatch repair function Active 01-Jul-2011
CA-2840526-A1 Method to determine dna mismatch repair function Active 01-Jul-2011
CA-2840526-C Method to determine dna mismatch repair function Active 01-Jul-2011 C12Q1/6883
To view Lynsight’s complete patent history, request access »

Lynsight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lynsight Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
TJT Technologies Corporation Minority
EIT Health Accelerator/Incubator
X-Europe Accelerator/Incubator
Nordic Mentor Network For Entrepreneurship Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Lynsight FAQs

  • When was Lynsight founded?

    Lynsight was founded in 2013.

  • Where is Lynsight headquartered?

    Lynsight is headquartered in Helsinki, Finland.

  • What is the size of Lynsight?

    Lynsight has 11 total employees.

  • What industry is Lynsight in?

    Lynsight’s primary industry is Diagnostic Equipment.

  • Is Lynsight a private or public company?

    Lynsight is a Private company.

  • What is the current valuation of Lynsight?

    The current valuation of Lynsight is .

  • What is Lynsight’s current revenue?

    The current revenue for Lynsight is .

  • How much funding has Lynsight raised over time?

    Lynsight has raised $8.45M.

  • Who are Lynsight’s investors?

    , TJT Technologies, EIT Health, X-Europe, and Nordic Mentor Network For Entrepreneurship are 5 of 8 investors who have invested in Lynsight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process